June” 24 ” 2022″ (Reuters)
Tallaalka COVID-19 dayrtan waxay u badan tahay inay ku saleysan yihiin kala duwanaanshaha Omicron ee coronavirus halkii ay ka ahaan lahaayeen nooca asalka ah,
In kasta oo khubarada qaar ay soo jeedinayaan inay kaliya u fidiyaan faa’iidooyin la taaban karo oo loogu talagalay dadka da’da ah iyo kuwa difaaca jirran.
(MRNA.O), Pfizer (PFE.N) and Novavax (NVAX.O) waxay tijaabinayeen tallaallo ku salaysan kala duwanaanshaha BA.1 Omicron ee ugu horreeyay kaas oo noqday mid awood badan jiilaalkii hore, taasoo horseeday kor u kaca caabuqyada.
Arbacadii, Moderna waxay sheegtay in tallaalkeeda la cusboonaysiiyay uu si wanaagsan uga soo horjeeday Omicron-hoosaadyadii dhawaa, iyo inay horay u sii waddo qorshayaasha lagu weydiinayo maamulayaasha oggolaansho. . read more
Tallaallada soo afjari kara farqiga u dhexeeya nooca asalka ah ee coronavirus iyo kala duwanaanshaha Omicron waxay u badan tahay inay “fog, aad uga wanaagsan yihiin” dayrta, sida uu qabo Trevor Bedford, cilmiga bayoolajiga ee Jaamacadda Washington oo si dhow ula socday isbeddellada SARS- coV-2 fayraska.
Bedford waxa uu sheegay in ay qaadan doonto wakhti aad u dheer in la buuxiyo shuruudaha sharci ee loogu badalo in lagu tolo talaal soo socda noocyada Omicron oo si degdeg ah u faafaya hadda.
“La qabsashada mid ka mid ah Omicrons-ka ayaa runtii muhiim ah,” ayuu yidhi, isagoo xusay boodboodka weyn ee tirada isbeddellada ka yimid noocii asalka ahaa ee ka soo baxay Shiinaha ilaa Omicron oo ku yaal qaybta borotiinka sare ee fayraska bartilmaameedka tallaalka.
Dr. Jesse Goodman, oo borofisar ka ah Dugsiga Caafimaadka ee Georgetown isla markaana hore u ahaan jiray saynisyahano sare oo FDA ah, ayaa sheegay in si ka duwan hargabka, maamulayaashu aysan khibrad ku filan u lahayn tallaallada COVID si ay ugu dhigmaan noocyada w壯陽藥 areegga wareegga iyada oo aan la helin tijaabooyin caafimaad.
Ururka Caafimaadka Adduunka (WHO) ayaa qorsheynaya inuu qiimeeyo waxtarka tallaallada loo dhisay Omicron, si la mid ah maamulayaasha caafimaadka qaranka sida Maamulka Cuntada iyo Dawooyinka ee Mareykanka.
Dr. Luciana Borio, oo ah ku-simaha madaxa saynisyahanada FDA, ayaa sheegtay in sayniska guud ahaan uu taageersan yahay fikradda ah in ay fiicnaan lahayd in la helo tallaalo si aad ah ugu dhow fayraska hadda wareegaya. (22UAy.DE)
Waxaan ku aragnaa taas dadka leh difaac isku-dhafan oo tallaalka iyo caabuqa,” ayuu yiri Borio. Weli, Borio iyo kuwa kale kuma qanacsana in qof walba mar kale la tallaalo. “Ma jirto wax caddaynaya in qof 27 jir ah oo caafimaad qaba uu u baahan yahay in dib loo tallaalo,” ayuu yiri Borio.
